Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series

S. Yamawaki (Tokyo, Japan), R. Tsuzuki (Tokyo, Japan), S. Soeda (Tokyo, Japan), O. Katsube (Tokyo, Japan), Y. Kono (Tokyo, Japan), M. To (Tokyo, Japan), Y. To (Tokyo, Japan)

Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4253

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Yamawaki (Tokyo, Japan), R. Tsuzuki (Tokyo, Japan), S. Soeda (Tokyo, Japan), O. Katsube (Tokyo, Japan), Y. Kono (Tokyo, Japan), M. To (Tokyo, Japan), Y. To (Tokyo, Japan). Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series. 4253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: